{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T03:40:22Z","timestamp":1788579622803,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL142834"],"award-info":[{"award-number":["R01 HL142834"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ekir.2022.12.002","type":"journal-article","created":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T12:51:29Z","timestamp":1670935889000},"page":"606-618","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Association of Kidney Function With Risk of Adverse Effects of Therapies for Atrial Fibrillation"],"prefix":"10.1016","volume":"8","author":[{"given":"Nisha","family":"Bansal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8461-5111","authenticated-orcid":false,"given":"Leila R.","family":"Zelnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3161-5732","authenticated-orcid":false,"given":"Jaejin","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa N.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Sum","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E.","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue Hee","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongjie","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan S.","family":"Go","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2022.12.002_bib1","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ekir.2022.12.002_bib2","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.amjcard.2013.05.063","article-title":"Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population","volume":"112","author":"Colilla","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ekir.2022.12.002_bib3","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1161\/CIRCULATIONAHA.111.020982","article-title":"Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study","volume":"123","author":"Alonso","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ekir.2022.12.002_bib4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2215\/CJN.03170509","article-title":"Prevalence of atrial fibrillation and its predictors in nondialysis patients with chronic kidney disease","volume":"5","author":"Ananthapanyasut","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2022.12.002_bib5","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1161\/CIRCEP.110.957100","article-title":"Association of chronic kidney disease with atrial fibrillation among adults in the United States: REasons for geographic and racial differences in stroke (REGARDS) study","volume":"4","author":"Baber","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.ekir.2022.12.002_bib6","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1097\/HJH.0b013e32833a7dfe","article-title":"Chronic kidney disease as an independent risk factor for new-onset atrial fibrillation in hypertensive patients","volume":"28","author":"Horio","year":"2010","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.ekir.2022.12.002_bib7","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ahj.2010.03.027","article-title":"Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC)","volume":"159","author":"Soliman","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.ekir.2022.12.002_bib8","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/CIRCULATIONAHA.112.107128","volume":"127","author":"Piccini","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ekir.2022.12.002_bib9","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.amjcard.2010.10.074","article-title":"Chronic kidney disease and CHADS(2) score independently predict cardiovascular events and mortality in patients with nonvalvular atrial fibrillation","volume":"107","author":"Nakagawa","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ekir.2022.12.002_bib10","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1161\/CIRCULATIONAHA.108.816082","article-title":"Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study","volume":"119","author":"Go","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ekir.2022.12.002_bib11","article-title":"Impact of chronic kidney disease on risk of incident atrial fibrillation and subsequent survival in medicare patients","volume":"1","author":"Nelson","year":"2012","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.ekir.2022.12.002_bib12","article-title":"Incident atrial fibrillation and risk of death in adults with chronic kidney disease","volume":"3","author":"Bansal","year":"2014","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.ekir.2022.12.002_bib13","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJMoa1105594","article-title":"Stroke and bleeding in atrial fibrillation with chronic kidney disease","volume":"367","author":"Olesen","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2022.12.002_bib14","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1161\/CIRCULATIONAHA.112.123992","article-title":"Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease","volume":"127","author":"Bansal","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ekir.2022.12.002_bib15","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1097\/01.ASN.0000135969.33773.0B","article-title":"\u201cRenalism\u201d: inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency","volume":"15","author":"Chertow","year":"2004","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2022.12.002_bib16","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.2174\/0929867323666160309114246","article-title":"Cardiac arrhythmias in patients with chronic kidney disease: implications of renal failure for antiarrhythmic drug therapy","volume":"23","author":"Potpara","year":"2016","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.ekir.2022.12.002_bib17","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1056\/NEJMoa1007432","article-title":"Apixaban in patients with atrial fibrillation","volume":"364","author":"Connolly","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2022.12.002_bib18","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2022.12.002_bib19","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2022.12.002_bib20","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2022.12.002_bib21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1055\/s-0038-1647640","article-title":"Platelet function and the bleeding time in progressive renal failure","volume":"60","author":"Gordge","year":"1988","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ekir.2022.12.002_bib22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1055\/s-0038-1647445","article-title":"The decreased circulating platelet mass and its relation to bleeding time in chronic renal failure","volume":"65","author":"Michalak","year":"1991","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ekir.2022.12.002_bib23","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1001\/jama.2014.1334","article-title":"Warfarin, kidney dysfunction, and outcomes following acute myocardial infarction in patients with atrial fibrillation","volume":"311","author":"Carrero","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.ekir.2022.12.002_bib24","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1161\/STROKEAHA.110.600759","article-title":"Chronic kidney disease and drinking status in relation to risks of stroke and its subtypes: the Circulatory Risk in Communities Study (CIRCS)","volume":"42","author":"Shimizu","year":"2011","journal-title":"Stroke; J Cereb Circ"},{"key":"10.1016\/j.ekir.2022.12.002_bib25","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1093\/eurheartj\/ehr342","article-title":"Prevention of stroke and systemic embolism with Rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment","volume":"32","author":"Fox","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ekir.2022.12.002_bib26","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jstrokecerebrovasdis.2012.05.007","article-title":"Stroke risk and efficacy of apixaban in atrial fibrillation patients with moderate chronic kidney disease","volume":"21","author":"Eikelboom","year":"2012","journal-title":"J\u00a0Stroke Cerebrovasc Dis Off J Natl Stroke Assoc"},{"key":"10.1016\/j.ekir.2022.12.002_bib27","doi-asserted-by":"crossref","first-page":"h246","DOI":"10.1136\/bmj.h246","article-title":"The association between kidney function and major bleeding in older adults with atrial fibrillation starting warfarin treatment: population based observational study","volume":"350","author":"Jun","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.ekir.2022.12.002_bib28","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1179\/1743132812Y.0000000041","article-title":"Kidney dysfunction at the time of intracerebral hemorrhage is associated with increased in-hospital mortality: a retrospective observational cohort study","volume":"34","author":"Rhoney","year":"2012","journal-title":"Neurol Res"},{"key":"10.1016\/j.ekir.2022.12.002_bib29","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1093\/eurheartj\/ehs274","article-title":"Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the Aristotle trial","volume":"33","author":"Hohnloser","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ekir.2022.12.002_bib30","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/CIRCULATIONAHA.116.022361","article-title":"Impact of renal function on outcomes with edoxaban in the ENGAGE AF-TIMI 48 trial","volume":"134","author":"Bohula","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.ekir.2022.12.002_bib31","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ahj.2004.11.015","article-title":"Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study","volume":"149","author":"DiMarco","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.ekir.2022.12.002_bib32","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1016\/j.jacc.2014.09.051","article-title":"Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study","volume":"64","author":"Bonde","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ekir.2022.12.002_bib33","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1161\/CIRCHEARTFAILURE.109.932558","article-title":"Efficacy and safety of carvedilol in treatment of heart failure with chronic kidney disease: a meta-analysis of randomized trials","volume":"4","author":"Wali","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ekir.2022.12.002_bib34","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1053\/j.ajkd.2014.06.009","article-title":"Kidney function and population-based outcomes of initiating oral atenolol versus metoprolol tartrate in older adults","volume":"64","author":"Fleet","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2022.12.002_bib35","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.2215\/CJN.12991216","article-title":"Association of QT-prolonging medication use in CKD with electrocardiographic manifestations","volume":"12","author":"Snitker","year":"2017","journal-title":"Clin J Am Soc Nephrol CJASN"},{"key":"10.1016\/j.ekir.2022.12.002_bib36","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1111\/jce.14165","article-title":"Safety of catheter ablation for atrial fibrillation in the octogenarian population","volume":"30","author":"Romero","year":"2019","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.ekir.2022.12.002_bib37","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/jce.14979","article-title":"Safety and complications of catheter ablation for atrial fibrillation: predictors of complications from an updated analysis the National Inpatient Database","volume":"32","author":"Wu","year":"2021","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.ekir.2022.12.002_bib38","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/jce.13118","article-title":"Safety and clinical outcomes of catheter ablation of atrial fibrillation in patients with chronic kidney disease","volume":"28","author":"Ullal","year":"2017","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.ekir.2022.12.002_bib39","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1586\/14779072.6.8.1043","article-title":"Creating a research data network for cardiovascular disease: the CVRN","volume":"6","author":"Magid","year":"2008","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.ekir.2022.12.002_bib40","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in atrial fibrillation (ATRIA) Study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ekir.2022.12.002_bib41","article-title":"A\u00a0new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score","volume":"2","author":"Singer","year":"2013","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.ekir.2022.12.002_bib42","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A\u00a0new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ekir.2022.12.002_bib43","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ki.2010.483","article-title":"The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report","volume":"80","author":"Levey","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2022.12.002_bib44","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2022.12.002_bib45","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1001\/jama.290.20.2685","article-title":"Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?","volume":"290","author":"Go","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ekir.2022.12.002_bib46","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/heartjnl-2016-309842","article-title":"Kidney function and appropriateness of device therapies in adults with implantable cardioverter defibrillators","volume":"103","author":"Bansal","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.ekir.2022.12.002_bib47","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jacc.2011.03.031","article-title":"A\u00a0new risk scheme to predict warfarin-associated hemorrhage: the ATRIA (Anticoagulation and Risk Factors in atrial fibrillation) Study","volume":"58","author":"Fang","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ekir.2022.12.002_bib48","article-title":"Stability of high-quality warfarin anticoagulation in a community-based atrial fibrillation cohort: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study","volume":"5","author":"Dallalzadeh","year":"2016","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.ekir.2022.12.002_bib49","article-title":"Association of digoxin with mortality in patients with advanced chronic kidney disease: A population-based cohort study","volume":"16","author":"Yang","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.ekir.2022.12.002_bib50","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1378\/chest.15-1719","article-title":"Stroke, major bleeding, and mortality outcomes in warfarin users with atrial fibrillation and chronic kidney disease: a meta-analysis of observational studies","volume":"149","author":"Dahal","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.ekir.2022.12.002_bib51","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/ndt\/gfy031","article-title":"A\u00a0systematic review of direct oral anticoagulant use in chronic kidney disease and dialysis patients with atrial fibrillation","volume":"34","author":"Feldberg","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2022.12.002_bib52","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1016\/j.jacc.2017.03.600","article-title":"Non-vitamin K antagonist oral anticoagulant dosing in patients with atrial fibrillation and renal dysfunction","volume":"69","author":"Yao","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ekir.2022.12.002_bib53","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1001\/archinte.158.4.325","article-title":"Pharmacological effects of antiarrhythmic drugs: review and update","volume":"158","author":"Kowey","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ekir.2022.12.002_bib54","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1056\/NEJMsa020703","article-title":"Adverse drug events in ambulatory care","volume":"348","author":"Gandhi","year":"2003","journal-title":"N\u00a0Engl J Med"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024922018976?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024922018976?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T03:43:33Z","timestamp":1762832613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024922018976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S2468024922018976"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2022.12.002","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of Kidney Function With Risk of Adverse Effects of Therapies for Atrial Fibrillation","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2022.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc. on behalf of the International Society of Nephrology.","name":"copyright","label":"Copyright"}]}}